4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-050690
Options or other derivatives
- Director acquired 16,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Baynes Roy D. Director | 2018-09-11 | Grant or award · Stock Option (Right to Buy) | +16,500 | 16,500 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…